insitro Uncovers Novel Peripheral Obesity Target Through AI-Enabled Brown Fat Genetics

AI-enabled brown adipose tissue (BAT) phenotype unlocks population-scale human genetic discovery BAT-01 knockdown drives 15% body-weight reduction in ...

February 04, 2026 | Wednesday | News
Trace Biosciences Receives FDA IND Clearance for First Nerve-Specific Fluorescent Imaging Agent

Trace Biosciences, Inc., a clinical-stage biotechnology company developing nerve-targeted imaging agents,  announced that the U.S. Food and Drug Adm...

February 03, 2026 | Tuesday | News
Eli Lilly to Invest $3.5 Billion in Lehigh Valley Manufacturing Site for Next-Generation Weight-Loss Medicines

The $3.5 billion Lehigh Valley site will develop Lilly's next-generation weight-loss medicines, including retatrutide Company plans to create more than ...

February 03, 2026 | Tuesday | News
I Peace Establishes Human iPS Cells Derived From NKT Cells, Expanding Immune Cell Therapy Platform

Leading GMP cell therapy CDMO I Peace, Inc., specializing in induced pluripotent stem cells (iPSCs) and iPSC-derived cell therapies, announced that it ha...

February 03, 2026 | Tuesday | News
Illumina Deepens Leadership in Proteomics and Multiomics With Completed SomaLogic Acquisition

Deeply expands leadership in proteomics and multiomics Combined capabilities bring high scalability, flexibility, and affordability into protein an...

February 03, 2026 | Tuesday | News
KORU Medical Receives FDA Clearance for FreedomEDGE® Infusion System to Deliver UCB’s RYSTIGGO® in gMG

KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the ...

February 02, 2026 | Monday | News
Origami Therapeutics and Ipsen Enter Global Collaboration to Advance Disease-Modifying Therapy for Rare Neurodegenerative Disease

- Ipsen obtains exclusive option to global license a research program for a selective disease-modifying approach to neurodegenerative diseases ...

February 02, 2026 | Monday | News
Ardena Completes Divestment of Södertälje API Site to Nanologica AB

Ardena, a specialist CDMO and bioanalytical CRO enabling precision medicines and other complex therapies, today announced that it has completed the dives...

February 02, 2026 | Monday | News
Takeda CEO Christophe Weber Says FY2025 Is “Pivotal” as Company Raises Outlook Despite VYVANSE Erosion

  Year-to-Date Revenue Declined by 2.8% at Constant Exchange Rate (CER), 3.3% atActual Exchange Rates (AER); Impact of VYVANSE® Generics is T...

February 02, 2026 | Monday | Company results
Elevar Submits NDA for Lirafugratinib as Second-Line FGFR2-Driven Cholangiocarcinoma Therapy

  Elevar Therapeutics, Inc., a majority-owned subsidiary of HLB Co., Ltd. and a fully integrated biopharmaceutical company dedicated to elevating tre...

January 30, 2026 | Friday | News
Imviva Biotech’s CTD402 Granted FDA Orphan Drug Designation for Relapsed/Refractory T-ALL/LBL

Imviva Biotech, a clinical-stage biotechnology company developing next-generation allogeneic CAR-T cell therapies, announced that the U.S. Food and Drug ...

January 29, 2026 | Thursday | News
Boehringer Ingelheim’s Apecotrep Delivers 40% Proteinuria Reduction in Phase II Primary FSGS Trial

Apecotrep (BI 764198) is a potential first-in-class, oral, selective TRPC6 inhibitor being investigated as a novel, targeted, non-immunosuppressive the...

January 29, 2026 | Thursday | News
SamanTree Medical Secures €20M EIB Financing to Advance Real-Time Surgical Imaging

SamanTree Medical, a European leader in surgical imaging innovation, has secured €20 million in financing from the European Investment Bank (EIB). T...

January 28, 2026 | Wednesday | News
Longeveron Secures FDA Type C Meeting Ahead of Pivotal ELPIS II Data Readout in HLHS

ELPIS II top-line trial results are anticipated in the third quarter of 2026 Laromestrocel Biological License Application (BLA) submission for full tr...

January 28, 2026 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close